We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$8.3B
AUM Growth
+$43.3M
Cap. Flow
-$37.6M
Cap. Flow %
-0.45%
Top 10 Hldgs %
10.22%
Holding
1,543
New
158
Increased
349
Reduced
264
Closed
134

Sector Composition

Rank Sector Weight
1 Financials 24.81%
2 Industrials 15.36%
3 Technology 12.25%
4 Healthcare 9.83%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTSI icon
1351
UTStarcom
UTSI
$22M
$114K ﹤0.01%
12,150
SCKT icon
1352
Socket Mobile
SCKT
$3.92M
$113K ﹤0.01%
27,700
OCRX
1353
DELISTED
Ocera Therapeutics, Inc.
OCRX
$113K ﹤0.01%
97,265
-33,795
-26% -$39.3K
AWRE icon
1354
Aware
AWRE
$24M
$106K ﹤0.01%
20,523
+6,023
+42% +$28.8K
ABCD
1355
DELISTED
Cambium Learning Group, Inc.
ABCD
$104K ﹤0.01%
20,450
-550
-3% -$2.74K
CARM
1356
DELISTED
Carisma Therapeutics
CARM
$102K ﹤0.01%
3,250
FSI icon
1357
Flexible Solutions
FSI
$64.6M
$101K ﹤0.01%
55,707
SYBX
1358
DELISTED
Synlogic
SYBX
$101K ﹤0.01%
570
+141
+33% +$26K
CFBK icon
1359
CF Bankshares
CFBK
$239M
$99K ﹤0.01%
8,691
+2,809
+48% +$33.4K
XWEL icon
1360
XWELL
XWEL
$8.95M
$99K ﹤0.01%
+50
New +$105K
CHK
1361
DELISTED
Chesapeake Energy Corporation
CHK
$99K ﹤0.01%
100
-11
-10% -$11.8K
CRMD icon
1362
CorMedix
CRMD
$564M
$96K ﹤0.01%
44,940
APVO icon
1363
Aptevo Therapeutics
APVO
$4.96M
0
BSF
1364
DELISTED
Bear State Financial, Inc.
BSF
$95K ﹤0.01%
+10,000
New +$92.5K
RVP icon
1365
Retractable Technologies
RVP
$20.1M
$91K ﹤0.01%
70,877
NOVN
1366
DELISTED
Novan, Inc. Common Stock
NOVN
$91K ﹤0.01%
+2,269
New +$112K
CRD.A icon
1367
Crawford & Co Class A
CRD.A
$542M
$90K ﹤0.01%
11,600
-750
-6% -$6.04K
SCYX icon
1368
SCYNEXIS
SCYX
$37.4M
$90K ﹤0.01%
+625
New +$104K
DZSI
1369
DELISTED
DZS Inc. Common Stock
DZSI
$87K ﹤0.01%
14,420
SES
1370
DELISTED
Synthesis Energy Systems Inc.
SES
$79K ﹤0.01%
1,831
-6,158
-77% -$308K
AAME icon
1371
Atlantic American Corp
AAME
$31.8M
$78K ﹤0.01%
21,056
ALR
1372
DELISTED
AlerisLife Inc
ALR
$77K ﹤0.01%
5,141
-35,630
-87% -$645K
HLTH
1373
DELISTED
Nobilis Health Corp.
HLTH
$76K ﹤0.01%
40,000
DMTX
1374
DELISTED
Dimension Therapeutics, Inc
DMTX
$74K ﹤0.01%
50,800
-4,520
-8% -$6.14K
TARA icon
1375
Protara Therapeutics
TARA
$214M
$73K ﹤0.01%
1,180
-295
-20% -$16.5K

Similar funds

Bridgeway Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Bridgeway Capital Management held 1,543 positions worth $8.3B, up 0.52% from $8.26B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Bridgeway Capital Management's Q2 2017 filing shows 158 new, 349 increased, 264 reduced and 134 closed positions. Its largest new stake was Occidental Petroleum: 1,029,780 shares worth $61.7M. The largest sale was Williams Companies, an estimated $67M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Industrials and Technology.

  • Bridgeway Capital Management's largest Q2 2017 buy was Occidental Petroleum: 1,029,780 shares worth $61.7M.
  • Bridgeway Capital Management added most to Pfizer in Q2 2017, an estimated $51.3M increase.
  • Bridgeway Capital Management's biggest Q2 2017 reduction was T-Mobile US, cutting an estimated $62.8M.
  • Bridgeway Capital Management fully exited Williams Companies in Q2 2017, selling an estimated $67M.
  • Bridgeway Capital Management's ten largest holdings make up 10% of its $8.3B portfolio in Q2 2017.
  • Bridgeway Capital Management opened 158 new positions and closed 134 in Q2 2017.
  • Bridgeway Capital Management's portfolio value rose 0.52% quarter-over-quarter to $8.3B.

Based on Bridgeway Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.